Kama Sutra
Natural health product licensed in Canada
- Licence holder
- Kamsut Inc. dba The Kama Sutra Company
- NPN or DIN-HM
- 80039144
- Status
- Active licence
- Licence date
- 24 January 2013
- Revision date
- Not provided
- Form
- Gel
- Route of administration
- Topique
- Application type
- Non traditionnelle
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
EDTA de sodium, PEG-8, Poly(sorbate) 60, Poly(propylène glycol), Bleu brilliant FCF, Laque d'aluminium jaune FD&C No. 6, Hydroxyéthylcellulose, Eau purifiée
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | Not specified |
Uses authorised in Canada
Helps in temporarily prolonging time until ejaculation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur, in such a case, discontinue use.
Source
Official Health Canada record, licence 80039144
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.